vs
InnovAge Holding Corp.（INNV）与P3 Health Partners Inc.（PIII）财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是InnovAge Holding Corp.的1.6倍（$384.8M vs $239.7M）。InnovAge Holding Corp.净利率更高（4.4% vs -19.6%，领先24.1%）。InnovAge Holding Corp.同比增速更快（14.7% vs 3.8%）。过去两年InnovAge Holding Corp.的营收复合增速更高（11.4% vs -0.5%）
InnovAge Holding Corp是美国领先的老年护理服务商，主要运营老年人全包护理项目（PACE），为符合条件的高龄群体提供综合医疗、社会支持与日常生活协助，帮助老人居家养老，服务覆盖美国多个州。
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
INNV vs PIII — 直观对比
营收规模更大
PIII
是对方的1.6倍
$239.7M
营收增速更快
INNV
高出10.9%
3.8%
净利率更高
INNV
高出24.1%
-19.6%
两年增速更快
INNV
近两年复合增速
-0.5%
损益表 — Q2 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $239.7M | $384.8M |
| 净利润 | $10.6M | $-75.5M |
| 毛利率 | 22.0% | — |
| 营业利润率 | 5.5% | -40.0% |
| 净利率 | 4.4% | -19.6% |
| 营收同比 | 14.7% | 3.8% |
| 净利润同比 | 180.3% | -28.8% |
| 每股收益（稀释后） | $0.08 | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INNVPIII
| Q4 25 | $239.7M | $384.8M | ||
| Q3 25 | $236.1M | $345.3M | ||
| Q2 25 | $221.4M | $355.8M | ||
| Q1 25 | $218.1M | $373.2M | ||
| Q4 24 | $209.0M | $370.7M | ||
| Q3 24 | $205.1M | $362.1M | ||
| Q2 24 | $199.4M | $379.2M | ||
| Q1 24 | $193.1M | $388.5M |
净利润INNVPIII
| Q4 25 | $10.6M | $-75.5M | ||
| Q3 25 | $8.0M | $-31.6M | ||
| Q2 25 | $-785.0K | $-20.4M | ||
| Q1 25 | $-11.4M | $-20.5M | ||
| Q4 24 | $-13.2M | $-58.6M | ||
| Q3 24 | $-4.9M | $-46.5M | ||
| Q2 24 | $-1.7M | $-12.0M | ||
| Q1 24 | $-5.9M | $-18.7M |
毛利率INNVPIII
| Q4 25 | 22.0% | — | ||
| Q3 25 | 21.8% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | 18.7% | — | ||
| Q4 24 | 17.7% | — | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 18.3% | — | ||
| Q1 24 | 17.6% | — |
营业利润率INNVPIII
| Q4 25 | 5.5% | -40.0% | ||
| Q3 25 | 3.5% | -12.8% | ||
| Q2 25 | -1.0% | -9.6% | ||
| Q1 25 | -4.7% | -10.2% | ||
| Q4 24 | -6.0% | -37.4% | ||
| Q3 24 | -2.4% | -29.5% | ||
| Q2 24 | -2.4% | -8.3% | ||
| Q1 24 | -3.0% | -11.3% |
净利率INNVPIII
| Q4 25 | 4.4% | -19.6% | ||
| Q3 25 | 3.4% | -9.1% | ||
| Q2 25 | -0.4% | -5.7% | ||
| Q1 25 | -5.2% | -5.5% | ||
| Q4 24 | -6.3% | -15.8% | ||
| Q3 24 | -2.4% | -12.8% | ||
| Q2 24 | -0.9% | -3.2% | ||
| Q1 24 | -3.0% | -4.8% |
每股收益（稀释后）INNVPIII
| Q4 25 | $0.08 | $-23.08 | ||
| Q3 25 | $0.06 | $-9.67 | ||
| Q2 25 | $0.00 | $-6.23 | ||
| Q1 25 | $-0.08 | $-6.28 | ||
| Q4 24 | $-0.10 | $-23.13 | ||
| Q3 24 | $-0.04 | $-15.70 | ||
| Q2 24 | $-0.01 | $-7.37 | ||
| Q1 24 | $-0.04 | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $126.0M | $25.0M |
| 总债务越低越好 | — | $228.4M |
| 股东权益账面价值 | $256.8M | $-155.2M |
| 总资产 | $527.5M | $656.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INNVPIII
| Q4 25 | $126.0M | $25.0M | ||
| Q3 25 | $109.4M | $37.7M | ||
| Q2 25 | $105.9M | $38.6M | ||
| Q1 25 | $101.7M | $40.1M | ||
| Q4 24 | $86.9M | $38.8M | ||
| Q3 24 | $85.7M | $63.0M | ||
| Q2 24 | $102.8M | $73.1M | ||
| Q1 24 | $99.3M | $27.3M |
总债务INNVPIII
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | $60.0M | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | $66.0M | $133.1M | ||
| Q1 24 | — | $118.1M |
股东权益INNVPIII
| Q4 25 | $256.8M | $-155.2M | ||
| Q3 25 | $245.0M | $-18.7M | ||
| Q2 25 | $235.0M | $44.5M | ||
| Q1 25 | $238.0M | $63.3M | ||
| Q4 24 | $248.5M | $75.9M | ||
| Q3 24 | $260.9M | $120.5M | ||
| Q2 24 | $269.3M | $166.8M | ||
| Q1 24 | $281.1M | $146.6M |
总资产INNVPIII
| Q4 25 | $527.5M | $656.6M | ||
| Q3 25 | $510.2M | $683.6M | ||
| Q2 25 | $526.9M | $731.6M | ||
| Q1 25 | $536.6M | $783.9M | ||
| Q4 24 | $524.8M | $783.4M | ||
| Q3 24 | $527.7M | $833.3M | ||
| Q2 24 | $547.7M | $892.8M | ||
| Q1 24 | $527.4M | $855.9M |
负债/权益比INNVPIII
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.26× | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | 0.25× | 0.80× | ||
| Q1 24 | — | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.4M | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | $19.0M | — |
| 自由现金流率自由现金流/营收 | 7.9% | — |
| 资本支出强度资本支出/营收 | 1.0% | — |
| 现金转化率经营现金流/净利润 | 2.01× | — |
| 过去12个月自由现金流最近4个季度 | $49.4M | — |
8季度趋势，按日历期对齐
经营现金流INNVPIII
| Q4 25 | $21.4M | $-25.7M | ||
| Q3 25 | $3.9M | $-15.4M | ||
| Q2 25 | $9.0M | $-16.6M | ||
| Q1 25 | $24.6M | $-33.5M | ||
| Q4 24 | $6.8M | $-57.2M | ||
| Q3 24 | $-7.5M | $-22.6M | ||
| Q2 24 | $1.9M | $-10.2M | ||
| Q1 24 | $3.5M | $-20.0M |
自由现金流INNVPIII
| Q4 25 | $19.0M | — | ||
| Q3 25 | $-153.0K | — | ||
| Q2 25 | $8.8M | — | ||
| Q1 25 | $21.7M | — | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $-9.7M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $3.1M | — |
自由现金流率INNVPIII
| Q4 25 | 7.9% | — | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | 4.0% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | -4.7% | — | ||
| Q2 24 | -0.7% | — | ||
| Q1 24 | 1.6% | — |
资本支出强度INNVPIII
| Q4 25 | 1.0% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率INNVPIII
| Q4 25 | 2.01× | — | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INNV
暂无分部数据
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
